PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.79%
Net income growth above 1.5x TSM's 3.86%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
15.22%
D&A growth well above TSM's 2.99%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
4.55%
Deferred tax of 4.55% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-1.35%
Both cut yoy SBC, with TSM at -7.79%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-58.60%
Negative yoy working capital usage while TSM is 110.32%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-292.38%
AR is negative yoy while TSM is 224.84%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-56.86%
Both reduce yoy inventory, with TSM at -17.38%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-23.53%
Both negative yoy AP, with TSM at -90.71%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
2728.57%
Growth well above TSM's 443.13%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
3050.00%
Well above TSM's 80.62%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-10.67%
Negative yoy CFO while TSM is 36.26%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-39.81%
Negative yoy CapEx while TSM is 12.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-125.00%
Both yoy lines negative, with TSM at -17.51%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-99.85%
We reduce yoy sales while TSM is 14.51%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.15%
Both yoy lines negative, with TSM at -115.39%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-112.02%
We reduce yoy invests while TSM stands at 5.33%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.44%
Buyback growth of 56.44% while TSM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.